The Framingham prediction rule is not valid in a European population of treated hypertensive patients

被引:77
作者
Bastuji-Garin, S [1 ]
Deverly, A
Moyse, D
Castaigne, A
Mancia, G
de Leeuw, PW
Ruilope, LM
Rosenthal, T
Chatellier, G
机构
[1] Univ Paris 12, Hop Henri Mondor, AP HP, Dept Sante Publ, F-94010 Creteil, France
[2] Univ Paris 12, Hop Henri Mondor, AP HP, Dept Cardiol, F-94010 Creteil, France
[3] Bayer, Puteaux La Defense, France
[4] DMSA, Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Dept Med Informat, Paris, France
[6] Univ Milan, Cattedra Med Interna, Milan, Italy
[7] Univ Maastricht, Maastricht, Netherlands
[8] Univ Madrid, Hosp 12 Octubre, Dept Nephrol, Madrid 3, Spain
[9] Tel Aviv Univ, Chaim Sheba Med Ctr, Hypertens Unit, IL-69978 Tel Aviv, Israel
关键词
coronary heart disease; stroke; risk factors; risk prediction; European cohort;
D O I
10.1097/00004872-200210000-00016
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background Stratification of population groups according to cardiovascular risk level is recommended for primary prevention. Objective To assess whether the Framingham models could accurately predict the absolute risk of coronary heart disease (CHD) and stroke in a large cohort of middle-aged European patients with hypertension, and rank individual patients according to actual risk. Design A prospective cohort study comparing the actual risk with that predicted by either the Framingham equations or models derived from the INSIGHT study. Patients and setting From the INSIGHT prospective trial, conducted in eight countries of Western Europe and Israel, we selected 4407 European patients younger than 75 years without previous cardiovascular events. Interventions None. Main outcome measures Major cardiovascular events. Results In this population (45% men, mean age 64.1 years), 124 (2.8%) patients had CHD and 96 (2.2%) had strokes after a median follow-up of 3.7 years. Overestimation of absolute CHD risk by the Framingham equation was observed in all countries (from 2% in the UK to 7% in France), whereas predicted risk of stroke was close to the actual risk. However, patients in the highest risk quintile within each country had a threefold greater risk of a cardiovascular event than those in the lowest quintile. Conclusions The Framingham models should not be used to predict absolute CHD risk in the European population as a whole. However, these models may be used within each country, provided that cut-off points defining high-risk patients have been determined within each country. J Hypertens 20:1973-1980 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1973 / 1980
页数:8
相关论文
共 23 条
  • [1] CARDIOVASCULAR-DISEASE RISK PROFILES
    ANDERSON, KM
    ODELL, PM
    WILSON, PWF
    KANNEL, WB
    [J]. AMERICAN HEART JOURNAL, 1991, 121 (01) : 293 - 298
  • [2] [Anonymous], 1991, CARDIOVASC RISK FACT
  • [3] Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    Brown, MJ
    Palmer, CR
    Castaigne, A
    de Leeuw, PW
    Mancia, G
    Rosenthal, T
    Ruilope, LM
    [J]. LANCET, 2000, 356 (9227) : 366 - 372
  • [4] Brown MJ, 1998, J HYPERTENS, V16, P2113
  • [5] Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
    D'Agostino, RB
    Grundy, S
    Sullivan, LM
    Wilson, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 180 - 187
  • [6] Primary and subsequent coronary risk appraisal: New results from The Framingham Study
    D'Agostino, RB
    Russell, MW
    Huse, DM
    Ellison, RC
    Silbershatz, H
    Wilson, PWF
    Hartz, SC
    [J]. AMERICAN HEART JOURNAL, 2000, 139 (02) : 272 - 281
  • [7] STROKE RISK PROFILE - ADJUSTMENT FOR ANTIHYPERTENSIVE MEDICATION - THE FRAMINGHAM-STUDY
    DAGOSTINO, RB
    WOLF, PA
    BELANGER, AJ
    KANNEL, WB
    [J]. STROKE, 1994, 25 (01) : 40 - 43
  • [8] Dréau H, 2001, METHOD INFORM MED, V40, P6
  • [9] DUCIMETIERE P, 1980, LANCET, V1, P1346
  • [10] Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    Grundy, SM
    Pasternak, R
    Greenland, P
    Smith, S
    Fuster, V
    [J]. CIRCULATION, 1999, 100 (13) : 1481 - 1492